Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Sykaras, Alexandros G ^a,b   Demenis, Claire ^a   Case, R Maynard ^a   McLaughlin, John T ^a   Smith, Craig P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; COMPLEMENTARY DNA; ENDOCANNABINOID; ENDOCANNABINOID RECEPTOR; ENHANCED GREEN FLUORESCENT PROTEIN; FATTY ACID DERIVATIVE; FATTY ACID RECEPTOR; G PROTEIN COUPLED RECEPTOR 119; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 40; G PROTEIN COUPLED RECEPTOR 41; G PROTEIN COUPLED RECEPTOR 43; MESSENGER RNA; RECEPTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DUODENUM; ENTEROENDOCRINE CELL; ENTEROENDOCRINE I CELL; INTESTINE; MALE; MOUSE; NONHUMAN; NUTRIENT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

ANIMALS; DNA, COMPLEMENTARY; DUODENUM; ENDOCANNABINOIDS; ENTEROENDOCRINE CELLS; FATTY ACIDS; GENE EXPRESSION; MALE; MICE; MICE, TRANSGENIC; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, G-PROTEIN-COUPLED; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84864491110     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042373     Document Type: Article

References (50)

1. Diakogiannaki E, Gribble FM, Reimann F, ((2011)) Nutrient detection by incretin hormone secreting cells. Physiol Behav 106:: 387--393.
2. Engelstoft MS, Egerod KL, Holst B, Schwartz TW, ((2008)) A gut feeling for obesity: 7TM sensors on enteroendocrine cells. Cell Metab 8:: 447--449.
3. Rindi G, Leiter AB, Kopin AS, Bordi C, Solcia E, ((2004)) The "normal" endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci 1014:: 1--12.
4. Sternini C, Anselmi L, Rozengurt E, ((2008)) Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes 15:: 73--78.
5. Moran GW, Leslie FC, Levison SE, Worthington J, McLaughlin JT, ((2008)) Enteroendocrine cells: neglected players in gastrointestinal disorders? Therap Adv Gastroenterol 1:: 51--60.
6. Buchan AM, Polak JM, Solcia E, Capella C, Hudson D, et al. ((1978)) Electron immunohistochemical evidence for the human intestinal I cell as the source of CCK. Gut 19:: 403--407.
7. Smith GP, Jerome C, Norgren R, ((1985)) Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am J Physiol 249:: R638--641.
8. Polak JM, Bloom SR, Rayford PL, Pearse AG, Buchan AM, et al. ((1975)) Identification of cholecystokinin-secreting cells. Lancet 2:: 1016--1018.
9. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA, ((1985)) Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 75:: 1144--1152.
10. Chandra R, Liddle RA, ((2007)) Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 14:: 63--67.
11. Liou AP, Lu X, Sei Y, Zhao X, Pechhold S, et al. ((2011)) The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology 140:: 903--912.
12. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, et al. ((2003)) The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278:: 11303--11311.
13. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, et al. ((2003)) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:: 173--176.
14. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, et al. ((2005)) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:: 90--94.
15. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, et al. ((2010)) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:: 687--698.
16. McLaughlin J, Grazia Luca M, Jones MN, D'Amato M, Dockray GJ, et al. ((1999)) Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 116:: 46--53.
17. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, et al. ((2003)) The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278:: 11312--11319.
18. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, et al. ((2003)) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278:: 25481--25489.
19. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, et al. ((2012)) Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2. Diabetes.
20. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, et al. ((2008)) Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105:: 16767--16772.
21. Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, et al. ((2006)) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3:: 167--175.
22. Hansen KB, Rosenkilde MM, Knop FK, Wellner N, Diep TA, et al. ((2011)) 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab 96:: E1409--1417.
23. Lauffer LM, Iakoubov R, Brubaker PL, ((2009)) GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 58:: 1058--1066.
24. Overton HA, Fyfe MC, Reynet C, ((2008)) GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. Br J Pharmacol 153 (Suppl 1): S76--81.
25. Chu ZL, Carroll C, Alfonso J, Gutierrez V, He H, et al. ((2008)) A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. Endocrinology 149:: 2038--2047.
26. Chu ZL, Jones RM, He H, Carroll C, Gutierrez V, et al. ((2007)) A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 148:: 2601--2609.
27. Flock G, Holland D, Seino Y, Drucker DJ, ((2011)) GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms. Endocrinology 152:: 374--383.
28. de Lartigue G, Lur G, Dimaline R, Varro A, Raybould H, et al. ((2010)) EGR1 Is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons. Endocrinology 151:: 3589--3599.
29. Burdyga G, Varro A, Dimaline R, Thompson DG, Dockray GJ, ((2006)) Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance. Am J Physiol Gastrointest Liver Physiol 290:: G1289--1297.
30. Burdyga G, Lal S, Varro A, Dimaline R, Thompson DG, et al. ((2004)) Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J Neurosci 24:: 2708--2715.
31. Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann F, ((2009)) Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52:: 289--298.
32. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, et al. ((2008)) Glucose sensing in L cells: a primary cell study. Cell Metab 8:: 532--539.
33. Liou AP, Sei Y, Zhao X, Feng J, Lu X, et al. ((2011)) The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol 300:: G538--546.
34. Tolhurst G, Zheng Y, Parker HE, Habib AM, Reimann F, et al. ((2011)) Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP. Endocrinology 152:: 405--413.
35. Wang Y, Chandra R, Samsa LA, Gooch B, Fee BE, et al. ((2011)) Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor. Am J Physiol Gastrointest Liver Physiol 300:: G528--537.
36. Tolhurst G, Reimann F, Gribble FM, ((2009)) Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol 587:: 27--32.
37. Narisawa S, Huang L, Iwasaki A, Hasegawa H, Alpers DH, et al. ((2003)) Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol 23:: 7525--7530.
38. Chang SK, Dohrman AF, Basbaum CB, Ho SB, Tsuda T, et al. ((1994)) Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 107:: 28--36.
39. Edfalk S, Steneberg P, Edlund H, ((2008)) Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 57:: 2280--2287.
40. Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, et al. ((2008)) Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol 377:: 523--527.
41. McLaughlin JT, Lomax RB, Hall L, Dockray GJ, Thompson DG, et al. ((1998)) Fatty acids stimulate cholecystokinin secretion via an acyl chain length-specific, Ca2+-dependent mechanism in the enteroendocrine cell line STC-1. J Physiol 513 (Pt 1):: 11--18.
42. Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, et al. ((2012)) Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 7:: e35240.
43. Schwartz GJ, Fu J, Astarita G, Li X, Gaetani S, et al. ((2008)) The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8:: 281--288.
44. Wright K, Rooney N, Feeney M, Tate J, Robertson D, et al. ((2005)) Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 129:: 437--453.
45. D'Argenio G, Petrosino S, Gianfrani C, Valenti M, Scaglione G, et al. ((2007)) Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. J Mol Med (Berl) 85:: 523--530.
46. DiPatrizio NV, Astarita G, Schwartz G, Li X, Piomelli D, ((2011)) Endocannabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci U S A 108:: 12904--12908.
47. Di Marzo V, ((2011)) Endocannabinoids: an appetite for fat. Proc Natl Acad Sci U S A 108:: 12567--12568.
48. Habib AM, Richards P, Cairns LS, Rogers GJ, Bannon CA, et al. ((2012)) Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 153:: 3054--3065.
49. Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, et al. ((2003)) A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425:: 917--925.
50. Spandidos A, Wang X, Wang H, Seed B, ((2010)) PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 38:: D792--799.